CAPN6 (5C5) Monoclonal Antibody

$Lane 1: Human Placenta lysates; probed with CAPN6 (5C5) Monoclonal Antibody, unconjugated (bsm-51290M) at 1:1000 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.$

Lane 1: Human Placenta lysates; probed with CAPN6 (5C5) Monoclonal Antibody, unconjugated (bsm-51290M) at 1:1000 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.

$A549 cells probed with using CAPN6 (5C5) Monoclonal Antibody bsm-51290M at 1:25 for 60 minutes at 37\u00baC followed by secondary antibody at 1:400 (green), compared to an isotype control of mouse IgG1 (blue).$

A549 cells probed with using CAPN6 (5C5) Monoclonal Antibody bsm-51290M at 1:25 for 60 minutes at 37\u00baC followed by secondary antibody at 1:400 (green), compared to an isotype control of mouse IgG1 (blue).

Applications

Reactivity

Human
Mouse

Overview
Catalog #	bsm-51290M
Product Name	CAPN6 (5C5) Monoclonal Antibody
Applications	WB FCM
Reactivity	Human, Mouse
Specifications
Conjugation	Unconjugated
Host	Mouse
Source	This CAPN6 antibody is generated from a mouse immunized with a recombinant protein of human CAPN6.
Clonality	Monoclonal
Clone #	5C5
Isotype	IgG1
Concentration	0.5ug/ul
Purification	Purified by Protein G.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Store at -20C for 12 months.
Target
Gene ID	827
Swiss Prot	Q9Y6Q1
Synonyms	CANPX; CAPNX; CalpM; DJ914P14.1; Calpain-6; Calpain-like protease X-linked; Calpamodulin; CAPN6
Background	Microtubule-stabilizing protein that may be involved in the regulation of microtubule dynamics and cytoskeletal organization. May act as a regulator of RAC1 activity through interaction with ARHGEF2 to control lamellipodial formation and cell mobility. Does not seem to have protease activity as it has lost the active site residues (By similarity).
Application Dilution
WB	1:300-5000
FCM	1:20-100